Cancer Monoclonal Antibodies Market Size Estimated to Reach $69.3 Billion by 2025
"The Growing Preference Towards the Specificity of Monoclonal Antibodies to Target Cancer is Likely to Aid in the Market Growth of Cancer Monoclonal Antibodies Market."
BriefingWire.com, 4/29/2021 - Cancer Monoclonal Antibodies Market size is estimated to reach $69.3 Billion by 2025, growing at a CAGR of 10.2% during the forecast period 2020-2025. Monoclonal Antibody are made by cloning a unique white blood cell. These are molecules produced in laboratory; engineered to serve as substitute antibodies that can restore and also enhance the immune systemâs attack on cancer cells. Technological advancements in genetic sequencing and target gene selection, growing preference towards the specificity of monoclonal antibodies to target cancer, rise in the government initiatives, increase in the female geriatric population, rise in the prevalence of breast cancer and rise in the adoption of unhealthy lifestyle are the factors that are set to drive the growth of the global market for the forecast period 2020-2025.